Nuvation Bio  logo
Nuvation Bio NUVB
$ 4.6 -0.65%

Annual report 2025
added 03-02-2026

report update icon

Nuvation Bio Long Term Debt Current 2011-2026 | NUVB

Annual Long Term Debt Current Nuvation Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.88 M 1.66 M 1.97 M 1.21 M 863 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.97 M 863 K 1.52 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.4 -0.71 % $ 360 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 95.5 3.83 % $ 27.2 B germanyGermany
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.92 -0.34 % $ 6.35 B israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.55 -0.78 % $ 16 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 20.37 -2.4 % $ 952 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.08 -2.16 % $ 436 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.21 -1.47 % $ 3.08 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 32.24 -4.1 % $ 2.14 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.13 -1.26 % $ 315 M usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
2.66 M - -55.98 % $ 2.15 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
257 K $ 1.0 -2.91 % $ 152 M germanyGermany
Immutep Limited Immutep Limited
IMMP
205 K $ 0.31 -2.52 % $ 1.08 B australiaAustralia
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
406 K - -6.63 % $ 13.9 M usaUSA